Page 82 - ITPS-7-2

INNOSC Theranostics and
Pharmacological Sciences Youth brain health check and dysregulation

2023;20(2):1118. doi: 10.1556/2006.2022.00087
doi: 10.3390/ijerph20021118 227. van der Meer PB, Fuentes JJ, Kaptein AA, et al. Therapeutic
effect of psilocybin in addiction: A systematic review. Front
217. Lyes M, Yang KH, Castellanos J, Furnish T. Microdosing Psychiatry. 2023;14:1134454.
psilocybin for chronic pain: A case series. Pain.
2023;164(4):698-702. doi: 10.3389/fpsyt.2023.1134454
doi: 10.1097/j.pain.0000000000002778 228. Cowie ME, Hodgins DC. Contingency management in
Canadian addiction treatment: Provider attitudes and use.
218. Cunningham CO, Starrels JL. Guideline promoting J Stud Alcohol Drugs. 2023;84(1):89-96.
buprenorphine for treatment of chronic pain:
Transformative yet underdeveloped. Ann Intern Med. doi: 10.15288/jsad.22-00036
2023;176(3):419-420. 229. Mide M, Arvidson E, Gordh AS. Clinical differences of
doi: 10.7326/M23-0229 mild, moderate, and severe gambling disorder in a sample
of treatment seeking pathological gamblers in Sweden.
219. Bernal-Sobrino JL, Arias-Horcajadas F, Varela- J Gambl Stud. 2023;39(3):1129-1153.
Rodríguez C, et al. A 3-year retrospective study of the
impact of integrating an addiction liaison team into an doi: 10.1007/s10899-022-10183-x
outpatient alcoholism treatment programme. Alcohol 230. Péter L, Paksi B, Magi A, et al. Severity of behavioral
Alcohol. 2023;58(5):515-522. addiction symptoms among young adults using
doi: 10.1093/alcalc/agad004 non-prescribed sedatives/hypnotics. Addict Behav
Rep. 2023;17:100485.
220. Sussman S, Galimov A, Ayala N, Sinclair DL. Web-based
evidence on the treatment of behavioral addictions in doi: 10.1016/j.abrep.2023.100485
United States model treatment centers. Eval Health Prof. 231. Tauscher JS, DePue MK, Swank J, Salloum RG.
2023;46(1):23-29. Determinants of preference for telehealth versus in-person
doi: 10.1177/01632787221130543 treatment for substance use disorders: A discrete choice
experiment. J Subst Use Addict Treat. 2023;146:208938.
221. Natal S, Young CC, Kaur K, et al. Applications of isradipine
in human addiction studies: A systematic literature review. doi: 10.1016/j.josat.2022.208938
Exp Clin Psychopharmacol. 2023;31(2):507-522. 232. Lo C, Mane M, Kim JH, et al. Treating addiction with deep
doi: 10.1037/pha0000633 brain stimulation: Ethical and legal considerations. Int J
Drug Policy. 2023;113:103964.
222. Rubenis AJ, Nation JA, Katz EC, Arunogiri S. Increasing
attendance in addiction treatment with limited resources: doi: 10.1016/j.drugpo.2023.103964
A narrative review. J Addict Med. 2023;17(1):13-20. 233. Davidson M, Rashidi N, Hossain MK, Raza A, Nurgali K,
doi: 10.1097/ADM.0000000000001033 Apostolopoulos V. Tryptophan and substance abuse:
Mechanisms and impact. Int J Mol Sci. 2023;24(3):2737.
223. Husain JM, Cromartie D, Fitzelle-Jones E, Brochier A,
Borba CPC, Montalvo C. A qualitative analysis of barriers doi: 10.3390/ijms24032737
to opioid agonist treatment for racial/ethnic minoritized 234. Wolfschlag M, Håkansson A. Drug-induced gambling
populations. J Subst Abuse Treat. 2023;144:108918. disorder: Epidemiology, neurobiology, and management.
doi: 10.1016/j.jsat.2022.108918 Pharmaceut Med. 2023;37(1):37-52.
224. Salehi M, Abbaspour Z, Molana A, Shahini N. Impulsivity, doi: 10.1007/s40290-022-00453-9
inhibition, and internet addiction in medical students of 235. Brandt L, Hu MC, Liu Y, et al. Risk of experiencing an
North of Iran. Front Psychiatry. 2023;13:1002625. overdose event for patients undergoing treatment with
doi: 10.3389/fpsyt.2022.1002625 medication for opioid use disorder. Am J Psychiatry.
2023;180(5):386-394.
225. Barnett KB, Amason J, Wagner D, Ray HE. Characteristics of
substance-addicted mothers that predict graduation from the doi: 10.1176/appi.ajp.20220312
family treatment court. J Nurs Scholarsh. 2023;55(3):637-645. 236. Zhang X, Yang H, Zhang K, et al. Effects of exercise or
doi: 10.1111/jnu.12890 tai chi on Internet addiction in college students and the
potential role of gut microbiota: A randomized controlled
226. Basenach L, Renneberg B, Salbach H, Dreier M, trial. J Affect Disord. 2023;327:404-415.
Wölfling K. Systematic reviews and meta-analyses of
treatment interventions for Internet use disorders: Critical doi: 10.1016/j.jad.2023.02.002
analysis of the methodical quality according to the PRISMA 237. Potenza MN, Baldacchino AM. Virtually there and back
guidelines. J Behav Addict. 2023;12(1):9-25. again: An overview of the 2021 and 2022 scientific annual

Volume 7 Issue 2 (2024) 22 doi: 10.36922/itps.1472